Canada· CA-DIN-02469375
PREVYMIS
A other antivirals product containing letermovir, registered in Canada by MERCK CANADA INC. The same ATC class is registered in 4 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Letermovir is registered in 4 of 19 countries.
Countries holding a registration under ATC J05AX (other antivirals), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 1 of them publish a price we can compare per daily dose
Letermovir · ATC J05AX
4 / 19 countries
- Canada
- Ireland
- Netherlands
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- LETERMOVIR
- Manufacturer
- MERCK CANADA INC
- Country
- Canada (CA)
- ATC code
- J05AX
- ATC class
- Other antivirals
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Letermovir in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomPrevymis 240mg tabletsMerck Sharp & Dohme (UK) Ltd
- FinlandPREVYMISMerck Sharp & Dohme B.V.
- SwitzerlandPrevymis 120 mg, GranulatMSD Merck Sharp & Dohme AG
- CzechiaPREVYMISMerck Sharp & Dohme B.V., Haarlem
- United StatesPREVYMISMerck Sharp & Dohme LLC
- FrancePREVYMIS 120 mg, granulés en sachetMERCK SHARP & DOHME (PAYS-BAS)
- IrelandPREVYMIS 120 mg granules in sachetMerck Sharp & Dohme BV,
- IcelandPrevymisMerck Sharp & Dohme B.V.*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Prevymis
- Liechtenstein · Prevymis
- Norway · Prevymis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f184e265-45cd-4f89-a736-81e01eb55405 GET /v1/drugs/f184e265-45cd-4f89-a736-81e01eb55405?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02469375",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "J05AX",
"schedule": [
"Prescription"
],
"drug_code": "95816",
"strengths": [
"240 MG"
],
"ahfs_class": null,
"substances": [
"LETERMOVIR"
],
"product_categorization": null
}See everything about letermovir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.